In non-small cell lung cancer (NSCLC) cells, CAG activates AMPK/ULK1/mTOR to promote autophagy, inhibit inflammatory signaling, and exert anti-tumor effects (Zhu et al., 2024). Here, ULK1 is linked to non-small cell lung carcinoma.